Use of PEG‐interferon alfa‐2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL
2004; Wiley; Volume: 43; Issue: 2 Linguagem: Inglês
10.1002/pbc.20084
ISSN1545-5017
AutoresLuca Lo Nigro, Paola Guardo, Milena La Spina, Elena Mirabile, Paola Pisana, Gino Schilirò, Paola Guardo,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoPediatric Blood & CancerVolume 43, Issue 2 p. 185-185 Letter to the Editor Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL Luca Lo Nigro MD, Corresponding Author Luca Lo Nigro MD lucaln@yahoo.com Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalyCenter of Pediatric Hematology Oncology, University of Catania, via S. Sofia 78, 95123 Catania, Italy.===Search for more papers by this authorPaola Guardo BD, Paola Guardo BD Clinical Pathology Service, M. Ascoli-Tomaselli Hospital, Catania, ItalySearch for more papers by this authorMilena La Spina MD, Milena La Spina MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorElena Mirabile PhD, Elena Mirabile PhD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorPaola Pisana MD, Paola Pisana MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorGino Schilirò MD, Gino Schilirò MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorPaola Guardo BD, Paola Guardo BD Clinical Pathology Service, M. Ascoli-Tomaselli Hospital, Catania, ItalySearch for more papers by this author Luca Lo Nigro MD, Corresponding Author Luca Lo Nigro MD lucaln@yahoo.com Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalyCenter of Pediatric Hematology Oncology, University of Catania, via S. Sofia 78, 95123 Catania, Italy.===Search for more papers by this authorPaola Guardo BD, Paola Guardo BD Clinical Pathology Service, M. Ascoli-Tomaselli Hospital, Catania, ItalySearch for more papers by this authorMilena La Spina MD, Milena La Spina MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorElena Mirabile PhD, Elena Mirabile PhD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorPaola Pisana MD, Paola Pisana MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorGino Schilirò MD, Gino Schilirò MD Center of Pediatric Hematology and Oncology, University of Catania, Catania, ItalySearch for more papers by this authorPaola Guardo BD, Paola Guardo BD Clinical Pathology Service, M. Ascoli-Tomaselli Hospital, Catania, ItalySearch for more papers by this author First published: 17 May 2004 https://doi.org/10.1002/pbc.20084Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume43, Issue2August 2004Pages 185-185 RelatedInformation
Referência(s)